AI assistant
Sending…
HARVARD BIOSCIENCE INC — Director's Dealing 2013
Nov 18, 2013
34975_dirs_2013-11-18_48890ae5-0c02-4aff-9a02-3920d5eca84d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-11-18
Reporting Person: Gagnon Robert E. (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-18 | Stock option (right to buy) | $4.31 | A | 150000 | Acquired | 2023-11-18 | Common Stock, par value $0.01 per share (150000) | Direct |
Footnotes
F1: The option vests in four equal annual installments over four years after the grant date.
More from HARVARD BIOSCIENCE INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 23
Major Shareholding Notification
2026
Mar 23
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17